Display search results for ** instead (326 products)

Showing 1-10 of 326

This issue of Vital Signs, released on February 4, 2014, discusses Roches collaboration with Foundation Medicine, Novartis potential anti-aging drug, and DNA Electronics; acquisition of nanoMR, Inc.

USD 500.00

USD 375.00 save 25 %

This issue of Vital Signs discusses the FDA's clearnace of the first 3-D printed prescription drug, Illumina's formation of consumer genomics company Helix, Response Genetics' acquisition of Cancer Genetics, and Roche's acquisition of GeneWEAVE.

USD 450.00

USD 337.50 save 25 %

Some analysts like to talk about the hype cycle for emerging technologies. In the early phases of a new technology's life cycle, expectations can quickly reach a peak of sometimes unjustified excitement which is quickly followed by a trough of disillusionment and a gradual realization of the technology's true potential for productivity.

USD 250.00

USD 187.50 save 25 %

We all know the Internet of Things (IoT) will dramatically change the products we manufacture and use, making them smart, connected, and, ultimately, more autonomous. But what impact will the IoT and all of those smart products have on the cultures and organizational structures of the companies that manufacture them?

USD 250.00

USD 187.50 save 25 %

This issue profiles using atoms to shape 2D crystals, using worm's eye view of roots in field to improve crops, and a novel imaging platform that speeds drug candidate screening.

USD 250.00

USD 187.50 save 25 %

This issue profiles making dye-sensitized solar cells more efficient, USING injectable 3D vaccines for infectious diseases and cancer, and business proposal intelligence software.

USD 250.00

USD 187.50 save 25 %

This issue profiles a novel vaccine for treatment of Parkinson’s Disease, cross-border money transfers enabled through digital currency, and a fly-inspired anti-fogging coating.

USD 250.00

USD 187.50 save 25 %

This issue profiles smart textiles for monitoring and transmitting bio-medical information, advanced materials R&D at the University of Washington, and a bioresorbable electronic implant to treat localized bacterial infections.

USD 250.00

USD 187.50 save 25 %

This issue profiles discovery of an approach to target acute myeloid leukemia, a promising injectable treatment for wounded soldiers, and a nanomaterial barrier for sensitive teeth.

USD 250.00

USD 187.50 save 25 %

This issue profiles tattoo-based noninvasive glucose monitoring devices, cloud-based predictive technology, and combining photo acoustic imaging with ultrasonics for point-of-care diagnostics.

USD 250.00

USD 187.50 save 25 %

Showing 1-10 of 326